Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Open Access Platforms for Sharing Clinical Trial Data

Open Access Platforms for Sharing Clinical Trial Data Letters Xinyang Hua, MSc termine how best to connect researchers with this increas- William H. Herman, MD, MPH ingly available resource. Philip Clarke, PhD Joseph S. Ross, MD, MHS Author Affiliations: School of Population and Global Health, University of Harlan M. Krumholz, MD, SM Melbourne, Victoria, Australia (Hua, Clarke); School of Public Health, University of Michigan, Ann Arbor, Michigan (Herman). Author Affiliations: Yale School of Medicine, New Haven, Connecticut. Corresponding Author: Philip Clarke, PhD, Centre for Health Policy, Corresponding Author: Joseph S. Ross, MD, MHS, Department of Medicine, School of Population and Global Health, University of Melbourne, Section of General Internal Medicine, Yale University School of Medicine, Level 4, 207 Bouverie St, Carlton Victoria 3053, Australia PO Box 208093, New Haven, CT 06520 (joseph.ross@yale.edu). (philip.clarke@unimelb@edu.au). Conflict of Interest Disclosures: The authors have completed and submitted Conflict of Interest Disclosures: The authors have completed and the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Ross and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Krumholz report receiving research grant funding through Yale University from Dr Herman reports receiving personal fees from Merck Sharp & Dohme, the US Food and Drug Administration to develop methods for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Open Access Platforms for Sharing Clinical Trial Data

JAMA , Volume 316 (6) – Aug 9, 2016

Loading next page...
 
/lp/american-medical-association/open-access-platforms-for-sharing-clinical-trial-data-THFRtLXBi0
Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2016.8794
pmid
27532929
Publisher site
See Article on Publisher Site

Abstract

Letters Xinyang Hua, MSc termine how best to connect researchers with this increas- William H. Herman, MD, MPH ingly available resource. Philip Clarke, PhD Joseph S. Ross, MD, MHS Author Affiliations: School of Population and Global Health, University of Harlan M. Krumholz, MD, SM Melbourne, Victoria, Australia (Hua, Clarke); School of Public Health, University of Michigan, Ann Arbor, Michigan (Herman). Author Affiliations: Yale School of Medicine, New Haven, Connecticut. Corresponding Author: Philip Clarke, PhD, Centre for Health Policy, Corresponding Author: Joseph S. Ross, MD, MHS, Department of Medicine, School of Population and Global Health, University of Melbourne, Section of General Internal Medicine, Yale University School of Medicine, Level 4, 207 Bouverie St, Carlton Victoria 3053, Australia PO Box 208093, New Haven, CT 06520 (joseph.ross@yale.edu). (philip.clarke@unimelb@edu.au). Conflict of Interest Disclosures: The authors have completed and submitted Conflict of Interest Disclosures: The authors have completed and the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Ross and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Krumholz report receiving research grant funding through Yale University from Dr Herman reports receiving personal fees from Merck Sharp & Dohme, the US Food and Drug Administration to develop methods for

Journal

JAMAAmerican Medical Association

Published: Aug 9, 2016

References